The purpose of the study is to evaluate how effective Milrinone, given through an intravenous infusion, is compared to a placebo in improving the neurological outcomes of patients three months after experiencing vasospasm following an aneurysmal subarachnoid hemorrhage. Participants in the study will receive either the Milrinone treatment or a placebo, and their progress will be monitored over a period of time to assess their recovery and overall health outcomes.

Throughout the study, various aspects of the participants’ health will be evaluated, including their recovery in terms of brain function and quality of life. The study will also look at the success of the treatment in terms of reducing the narrowing of blood vessels in the brain, as well as other health indicators such as the length of hospital stay and any changes in blood pressure or metabolism. The goal is to gather information that could help improve treatment strategies for patients with this serious condition.